Imagine finishing a difficult piece of work and opening a message that should take thirty seconds to answer.

You know what to say. You even begin the reply. Then you check something, remember something else, open another tab. By evening, the difficult work is finished and the small message has become a larger problem.

Perhaps the rest of your life contains similar discrepancies. You can see the solution to a complicated problem but lose the paper you need to act on it. You care about someone and forget to call. A productive morning gives way to an afternoon spent trying to persuade yourself to begin.

A stalled afternoon can follow you into the evening: frustration at unfinished work, embarrassment about another late reply, less patience for a conversation you wanted to enjoy.

From outside, things appear to be working. From inside, you can see the reminders, rehearsals, apologies, and late hours holding them together.

That is the private cost this article means by “high functioning.” The phrase describes the appearance of the day; it tells us very little about the effort required to get through it. Disorganization, procrastination, and forgetting everyday tasks are recognized features of adult ADHD. Being capable in other parts of life does not make those difficulties imaginary. [1]

You may want help with that cost. You may also be quite clear that you do not want Adderall.

Both belong in the conversation.

When the familiar answer does not fit

Perhaps you have tried a stimulant and disliked how you felt. Perhaps sleep or appetite became a concern. Perhaps you simply want to understand other options before choosing a medication. Your reason deserves to be heard in its own terms.

Stimulants help many adults with ADHD, and individual responses differ. Wanting another route is a reasonable starting point for a discussion about treatment. [2]

There are already established nonstimulant options. In the United States, atomoxetine and extended-release viloxazine are medicines used for adult ADHD. They have their own risks, interactions, and monitoring requirements; suitability depends on the person. ADHD care can also include cognitive behavioral therapy and practical support for everyday functioning. [3][4][1]

Still, if you have spent years working around the same difficulties, a different kind of promise can catch your attention: something that might make thinking feel less effortful, or leave more space between an impulse and an action.

That is where Semax, Selank, and the unexpected stories about GLP-1 medicines become interesting.

The question underneath the search is personal: could an ordinary day require less negotiation with yourself?

Semax and the appeal of a different route

Semax is a synthetic peptide that has been investigated for effects on attention and other brain functions. [5]

People are already trying Semax for difficulties like these. In one public discussion, a user described easier motivation and fewer impulsive purchases while also using other peptides. In another, a person trying it for ADHD described only a mild change and uncertainty about whether it was placebo. These unverified accounts show the range of experience behind the interest. [6][7]

In a small 1996 study, 16 male power-plant operators received Semax or placebo in a randomized, double-blind experiment. Some attention-task results under work fatigue favored Semax, although spontaneous false responses were mixed and sometimes increased. The experiment lasted two days and did not involve adults being treated for ADHD. [5]

There is also an older pediatric ADHD report. Twenty children received Semax within a larger, open study, and the authors reported improvement after a month. Three had irritability or sleep complaints, which the authors described as transient. The small group, lack of blinding, and study design leave considerable uncertainty about its relevance to adult treatment. [8]

These findings help explain the interest. They also locate the unanswered question. Better performance on a brief attention task and more reliable functioning across months of work, relationships, and household responsibilities are different outcomes.

For the reader who keeps losing track of commitments, the meaningful result would be a promise remembered while there is still time to keep it. That is the kind of improvement an adult ADHD study would need to examine.

Our related coverage at Recovery Science Digest, Why the Peptide Story Is So Persuasive, examines how a precise biological explanation can make a proposed benefit feel unusually convincing. The next question is whether the research follows that explanation all the way into a person's life. [9]

Selank and the wish for a quieter mind

Selank is another synthetic peptide, with small human studies in anxiety.

A 2014 study compared Selank with phenazepam in 60 adults with anxiety-related conditions. It reported anxiety benefits, but the study was open and short. On one cognitive test, performance in the Selank group was largely unchanged while the comparator group worsened. That distinction matters when interpreting claims of improved cognition. [10]

It is easy to imagine why this would interest someone whose unfinished tasks arrive with a running commentary of worry. If worry is consuming attention, reducing it might make concentrating feel easier. That is a plausible explanation to investigate; this anxiety study did not establish treatment of ADHD.

A separate 2020 experiment gave Semax, Selank, or placebo to 52 healthy adults and measured brain connectivity within minutes. It found changes involving the amygdala and temporal regions. It did not measure ADHD symptoms or whether participants became better at managing everyday responsibilities. [11]

For U.S. readers, the FDA flags additional uncertainties around compounded Semax and Selank acetate, including potential immune reactions related to peptide impurities or aggregation and inadequate safety information. These are material gaps when considering a compound whose appeal may include the hope of fewer tradeoffs. [12]

The GLP-1 reports are asking a different question

The stories about GLP-1 medicines often begin with a surprise. A person starts treatment for diabetes or weight management and notices something that seems to extend beyond eating.

In one public ADHD discussion, an Ozempic user described less compulsive shopping and binge eating. Another commenter described finishing errands, putting down the phone, and remembering what to bring. One line captured the significance of those ordinary events:

“I didn't have to reason with myself.” [13]

These are unverified personal accounts. They capture experiences people attribute to a medication, with no reliable way to separate its effect from other changes in their lives.

The reports also vary. In another discussion, people described reduced food preoccupation with no noticeable ADHD benefit. Some in the original discussion reported fatigue or worse mood. A collection of comments cannot tell us how often any of these outcomes occurs or what caused it. [14][13]

There is controlled research on a nearby question. A 2025 trial randomized 114 adults with overweight or obesity to tirzepatide, placebo, or liraglutide. Tirzepatide reduced food intake and several appetite and craving measures. The study did not assess ADHD symptoms. [15]

Tirzepatide acts on both GIP and GLP-1 receptors, although it is often included in everyday conversation about “GLP-1s.” The distinction helps keep the research attached to the actual medicine studied. [16]

One possible explanation for some positive reports is straightforward: when thoughts about food become less intrusive, a person may experience more attention available for other things. Changes in sleep, metabolic health, or concurrent treatment could also contribute. Those are hypotheses, and the ADHD-specific contribution remains unresolved.

Our targeted literature search through 18 October 2026 did not identify a published randomized trial establishing semaglutide or tirzepatide as treatment for adult ADHD. The search was not exhaustive. The personal reports and related research justify asking the question. They do not yet establish a predictable ADHD benefit. [17]

If you already take one of these medicines for an appropriate medical reason and notice a change, bring the details to your prescriber. Was it easier to start work? Did you interrupt less? Did food thoughts recede while appointments remained just as easy to forget?

The detail is where an interesting story becomes a useful clinical conversation.

Give the desired change a name

“Better focus” can hold several different wishes.

You might want to begin the task you have already decided to do. You might want to remember the agreement made yesterday. You might want a minor interruption to stay minor, or enough attention left at dinner to follow the person across from you.

Those wishes deserve more precision than a general promise of mental clarity.

Our article Personalization Is Not Guesswork begins with the problem of similar complaints arising from different circumstances. The same principle applies here: a useful plan starts with the actual difficulty, its timeline, and the outcome that would make a difference. [18]

Sleep belongs in that picture. Sleep deficiency can interfere with focusing, learning, and emotional responses. Our Sleep Is Strategic Infrastructure article develops that foundation. In ADHD care, sleep is a contributing factor worth assessing alongside the ADHD itself. [19][20]

Mood deserves similar care. Bring marked or persistent changes in mood and motivation into the assessment, including when they started and what else changed. ADHD can coexist with other mental health conditions, and a clinician needs that wider history to understand the problem. [1]

This is how the search becomes more useful. Instead of collecting everything that has ever been described as improving cognition, you begin identifying the help your own week requires.

Bring the week you actually live

Before your next appointment, write down three recurring moments you want help with. Keep them concrete:

  • I delay necessary replies until the delay becomes a problem.
  • I forget commitments even when they matter to me.
  • My ability to begin work varies enough to disrupt the rest of the day.

Add your reason for wanting to avoid Adderall, what you have already tried, and any changes in sleep, mood, medication, or health. A few examples are enough to begin; this does not need to become another system you struggle to maintain.

Ask what established options fit those goals, how improvement would be assessed, and what evidence an emerging option would need before it deserved a place in your care.

You can remain interested in Semax, Selank, and the GLP-1 findings while expecting an answer that reaches beyond the promise of a clearer mind.

Perhaps the day you want contains no extraordinary moment at all. The appointment is remembered. There is attention left for the conversation at dinner.

And the message gets answered while it is still just a message.